Navigation Links
Chimerix to Present at Stifel Nicolaus 2011 Healthcare Conference
Date:9/6/2011

DURHAM, N.C., Sept. 6, 2011 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that Kenneth I. Moch, President and Chief Executive Officer, will present at the Stifel Nicolaus 2011 Healthcare Conference being held September 7-9, 2011 at the Four Seasons Hotel in Boston, Massachusetts.  The Stifel Nicolaus Healthcare Conference showcases presentations from established and emerging public and private companies, including those engaged in biotechnology, diagnostics, healthcare IT & services, life science technology, major and specialty pharmaceuticals, and medical devices.  

Mr. Moch's presentation, scheduled for Friday, September 9 at 8:00 am ET in the Winthrop Room, will include an update on the company's clinical pipeline, which includes CMX001. CMX001 is being tested in ongoing placebo-controlled clinical trials and in open-label treatment protocols for the prophylaxis, preemption and treatment of dsDNA viruses, including herpes viruses, adenoviruses, and orthopox viruses.  In addition, CMX001 is being developed as a potential countermeasure in the event of a smallpox release.  

About Chimerix

Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health.  

The company's lead candidate, CMX001, is being developed as a potential broad spectrum, oral antiviral agent for the treatment or prevention of life-threatening double-stranded DNA (dsDNA) viral diseases.  To date, more than 550 patients have been dosed with CMX001 in placebo-controlled clinical trials and open-label treatment protocols, including over 250 individuals who have received CMX001 under Emergency Investigational New Drug Applications (EINDs) or as part of the CMX001-350 Open-Label Study to help treat life-threatening dsDNA viral diseases for
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Chimerix Commences Phase 2 Clinical Study of CMX001 for Prevention of Adenovirus Disease in Pediatric and Adult Hematopoietic Stem Cell Transplant Patients
2. Chimerix and BARDA Reach Agreement Ending GAO Review of Smallpox Antiviral Contract
3. Chimerix to Present at Two Upcoming Investor Conferences
4. Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox
5. Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157
6. Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research
7. Chimerixs PIM Conjugate Technology Reduces Risk of Nephrotoxicity for CMX001 and CMX157
8. Chimerix Appoints Two New Vice Presidents to Clinical Management Team
9. Chimerix to Present at Upcoming Investor Conferences
10. Chimerix Initiates Phase 1 Study of CMX157
11. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 Baylor Research Institute ... Translational Genomics Research Institute (TGen) in ... focus on accelerating early detection and treatments for patients with ... both institutions will lead to new clinical trials and access ... bridging the gap from bench to bedside across Baylor ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Specialty ... audit and been admitted to BPA Worldwide as ... Worldwide will track audience data for Specialty Pharmacy ... , “By becoming a member of BPA ... to providing our clients with the most reliable, ...
(Date:5/21/2015)... uBiome, the leading startup focused ... PicnicHealth, a healthcare company that collects and consolidates ... Bowel Disease (IBD) will receive a complementary PicnicHealth ... kit. Both companies were funded by Y Combinator ... more information on this partnership and how to ...
(Date:5/21/2015)... 21, 2015 W. R. Grace ... facility in Worms, Germany has received good manufacturing ... of the International Pharmaceutical Excipient Council (IPEC) Foundation. ... produce its SYLOID® FP brand of pharmaceutical grade ... following the Curtis Bay, Maryland (USA) and Sorocaba, ...
Breaking Biology Technology:Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4Specialty Pharmacy Times Joins BPA Worldwide 2uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2
... the rising trend toward miniaturization, carbon nanotubes which ... and possess several unique and very useful properties ... blocks in nanosized electronic and mechanical devices. But it ... tendency to clump together, that make it difficult for ...
... testament to tight integration and ... excellent ... ), a,leader in radiology and medical image and information management solutions,today ... than 100 facilities that use MEDITECH(TM) as their health,information system. AMICAS ...
... device industry to benefit ... trial recruitment efforts, MINNEAPOLIS, May 27 ... has strengthened the,pharmaceutical side of its business with ... a commitment to leveraging differentiators unique,to the medical ...
Cached Biology Technology:Weizmann Institute scientists create new nanotube structures 2AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 2AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 3ThreeWire Expands Presence in the Pharmaceutical Arena 2
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
(Date:5/19/2015)... NEW YORK , May 19, 2015  Technology ... resources both internally and in the cloud. Passwords and ... the use of OTP and standards-based specifications such as ... that the outmoded use of passwords presents for BYOD, ... needs a unified biometric identity protocol. ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2
... events in the Asia-Pacific region opened at the Hong ... international delegates from over 60 countries. The IOF Regionals ... 15, is organized by the International Osteoporosis Foundation (IOF) ... the Osteoporosis Society of Hong Kong. The Meeting ...
... 2013 The critical enzyme beta-secretase1 (BACE1) is known to ... have now found increased levels of BACE1 in brains with ... for conversion of mild cognitive impairment to AD and may ... in the January issue of The American Journal of ...
... cities vary greatly in their dependence on the global ... of its most common food in its regional hinterland, ... The Copenhagen hinterland produces less than half of the ... time, researchers have mapped the food systems of capital ...
Cached Biology News:Osteoporosis prevention strategies and new bone research focus of major Hong Kong meeting 2Enzyme BACE1 may be important in predicting onset of Alzheimer disease 2Scientists map food security and self-provision of major cities 2Scientists map food security and self-provision of major cities 3
Collected from calves that are 10 days old or less. Sterile, cell culture tested, US Origin...
... Target Retrieval Solution, pH 9 (x 10) ... pH 9, intended for heat-induced target retrieval ... well-suited for use on formalin-fixed, paraffin-embedded tissue ... 0.01 mol/L citrate buffer, pH 6, the ...
MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain...
... any scanner into a gel densitometer. Although ... the basic operation simply consists of converting ... into pixel density / intensity values through ... Turn your scanner into a high speed ...
Biology Products: